行情

SCPH

SCPH

scPharma
NASDAQ

实时行情|Nasdaq Last Sale

5.75
-0.46
-7.41%
休市 16:00 10/18 EDT
开盘
6.32
昨收
6.21
最高
6.46
最低
5.75
成交量
8.29万
成交额
--
52周最高
7.85
52周最低
2.440
市值
1.07亿
市盈率(TTM)
-3.9774
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

SCPH 新闻

  • 自2016年以来 企业利润从未面临如此大的压力
  • 新浪美股.3小时前
  • 瑞银董事长警告:英国脱欧或引发广泛的"投资者罢工"
  • 新浪美股.4小时前
  • 重要部门偃旗息鼓 Caterpillar跑输标普500指数
  • 新浪财经-自媒体综合.7小时前
  • 三星两款手机,被曝高危漏洞!又一场电池门风暴?
  • 央视财经.7小时前

更多

所属板块

医疗设备、用品及经销
+0.02%
医疗设备和用品
+0.23%

热门股票

名称
价格
涨跌幅

SCPH 简况

scPharmaceuticals, Inc., is a biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The Company's products administered subcutaneously through the sc2Wear Infusor. The Company’s pipeline programs include: scFurosemide lead product candidate, Furoscix, consists of its proprietary subcutaneous formulation of furosemide delivered via sc2Wear Infusor for diuresis in heart failure patients outside of the acute care setting. The Company has completed two pivotal clinical studies, four exploratory clinical studies, and 12 human factor studies for Furoscix, and scCeftriaxone an antibiotic used intravenously for the treatment of infections caused by gram-positive and gram-negative organisms.
展开

Webull提供Scpharmaceuticals Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。